Prescription drug · ANDA
desogestrel and ethinyl estradiol and ethinyl estradiol NDC 79929-020
Kit · Naari Pte. Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 79929-020-07 | 79929002007 | 3 BLISTER PACK in 1 POUCH (79929-020-07) / 1 KIT in 1 BLISTER PACKMarketed from Apr 5, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- desogestrel and ethinyl estradiol and ethinyl estradiol
- Generic name (nonproprietary)
- desogestrel and ethinyl estradiol and ethinyl estradiol
- Dosage form
- Kit
- Labeler
- Naari Pte. Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209170
- Marketing start
- Listing expires
- Identifiers
- Product ID 79929-020_16ab3ee5-1f7e-7ef9-e063-6294a90a2bacSPL ID 16ab3ee5-1f7e-7ef9-e063-6294a90a2bacSPL set ID f8961550-d103-8ee6-e053-6294a90a7571RxCUI 248310, 249357, 748797, 759743
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N479929002007followed by a unit qualifier and the quantityPackage 79929-0020-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table II lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates. TABLE II: Percentage of women experiencing an unintended pregnancy during the first year of typical use …
Excerpt only. Read the full label for complete information.